News Posts List
New kidney cancer drug: linifanib
11/18/2010
In an open label trial, 53 patients who had failed sunitinib therapy were given once-daily doses of 0.25mg/kg.
Cancer Caregiver Survey Results
11/17/2010
Navigating Cancer surveyed 326 cancer caregivers through an online survey in October 2010. We defined a cancer caregiver as someone who provides unpaid assistance such as personal care, help with medications and other treatments, transportation to doctors appointments and arranging services. The survey results revealed significant emotional, financial and physical strain on the cancer caregiver community, as well as a lack of comprehensive resources to support their needs.
Warnings On Cigarette Packages And Advertising To Become Much Starker
11/14/2010
443,000 people die each year in the USA as a result of tobacco use - the leading cause of preventable and premature death in the country. 1,200 people each day lose their lives because they smoke or used to smoke regularly.
Here's What People Are Saying About Kidney Cancer
11/12/2010
More than 23,000 people interact on the Kidney Cancer Association's Facebook Fan Page
New Kidney Cancer Surgery Technique Could Reduce Organ Damage
11/11/2010
Dr. Inderbir S. Gill, pioneer of this new technique based at the University of Southern California said: "Good kidney function over the long-term is particularly important in patients with kidney cancer.
AACR News: Long-term statin use 'unlikely to increase cancer risk' [AUDIO]
11/10/2010
New research reveals long-term use of statins is unlikely to substantially increase or decrease overall cancer risk.
Frontiers in Cancer Prevention Research
11/09/2010
A brief overview of the Ninth Annual American Association for Cancer Research meeting in Philadelphia. This is billed as "The world's most comprehensive transdisciplinary cancer prevention meeting." Kidney Cancer Association CEO Bill Bro reports from the Pennsylvania Convention Center.
2nd Annual Jeff Beitel 5K Race A Big Success
11/09/2010
How Medicare Killed the Family Doctor
11/08/2010
Low government payment rates became the private-sector benchmark, resulting in fragmented care.
Fatigue in Renal Cell Carcinoma: The Hidden Burden of Current Targeted Therapies
11/06/2010
Fatigue remains a prominent toxicity with current targeted therapies. Future agents that show better selectivity and potency than current targeted therapies should help to provide better efficacy and tolerability.
News Feed